177Lu-DOTATATE Treatment In Unresectable Neuroendocrine Tumors: Our Experience

被引：0
|
作者：
Agudelo, M. [1 ]
Bello-Arques, P. [2 ]
Olivan-Sasot, P. [2 ]
Prado-Wohlwend, S. [2 ]
Sanchez-Vano, R. [2 ]
Yepes-Agudelo, A. [2 ]
Martinez-Sanchis, B. [2 ]
Bernal-Vergara, J. [2 ]
Figueroa-Ardila, G. [2 ]
机构：
[1] Hosp Univ & Politecn La Fe Valencia, Valencia, Spain
[2] Hosp Univ & Politecn La Fe, Valencia, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-07340
引用
收藏
页码：S596 / S597
页数：2
相关论文
共 50 条
  • [1] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [2] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Matuchansky, Claude
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1391
  • [3] Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors
    Aljubran, Ali
    Badran, Ahmed
    Alrowaily, Mohamed
    Raef, Hussein
    Alzahrani, Ahmed M.
    Almuhaideb, Ahmed
    Almanea, Hadeel
    El-Dali, Abdelmoneim
    Tuli, Mahmoud
    Bazarbashi, Shouki
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (02) : 164 - 168
  • [4] Toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Navarro Martinez, T.
    Ajuria Illarramendi, O.
    Lopez Villar, I.
    Azpeitia Hernandez, P.
    Gutierrez Guerrero, M.
    Paredes Rodriguez, P.
    Orduna Diez, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S471 - S471
  • [5] Dosimetric studies of 177Lu-DOTATATE administered into neuroendocrine tumors
    Gupta, Santosh
    Singla, Suhas
    Chakraborty, Sudipta
    Banerjee, Sharmila
    Das, Tapas
    Venkatesh, Meera
    Bal, C.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [6] Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with 177Lu-DOTATATE
    Roth, Daniel
    Gustafsson, Johan
    Warfvinge, Carl Fredrik
    Sundlov, Anna
    Akesson, Anna
    Tennvall, Jan
    Gleisner, Katarina Sjogreen
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (03): : 399 - 405
  • [7] Dosimetry of 177Lu-DOTATATE administered into neuroendocrine tumors - An initial experience from India
    Gupta, Santosh
    Meera, V
    Malhotra, A.
    Kumar, Prateek
    Bal, Chandersekhar
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [8] Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
    Sansovini, Maddalena
    Severi, Stefano
    Ambrosetti, Alice
    Monti, Manuela
    Nanni, Oriana
    Sarnelli, Anna
    Bodei, Lisa
    Garaboldi, Lucia
    Bartolomei, Mirco
    Paganelli, Giovanni
    [J]. NEUROENDOCRINOLOGY, 2013, 97 (04) : 347 - 354
  • [9] A shared experience in the treatment of neuroendocrine tumors (NET) with 177 Lu dotatate
    Lobo, G.
    Veras, M.
    Gomes, G.
    Tinoco Mesquita, C.
    Magalhaes, J.
    Hungria, P.
    Ramos, R.
    Barlete, A.
    Santos, T.
    Sadeck, G.
    Ker, W.
    Lavatori, N.
    Cotrado, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S419 - S419
  • [10] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Strosberg, J.
    El-Haddad, G.
    Wolin, E.
    Hendifar, A.
    Yao, J.
    Chasen, B.
    Mittra, E.
    Kunz, P. L.
    Kulke, M. H.
    Jacene, H.
    Bushnell, D.
    O'Dorisio, T. M.
    Baum, R. P.
    Kulkarni, H. R.
    Caplin, M.
    Lebtahi, R.
    Hobday, T.
    Delpassand, E.
    Van Cutsem, E.
    Benson, A.
    Srirajaskanthan, R.
    Pavel, M.
    Mora, J.
    Berlin, J.
    Grande, E.
    Reed, N.
    Seregni, E.
    Oberg, K.
    Sierra, M. Lopera
    Santoro, P.
    Thevenet, T.
    Erion, J. L.
    Ruszniewski, P.
    Kwekkeboom, D.
    Krenning, E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02): : 125 - 135
12345